in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
GSK to spend $1 billion on raising stake in Indian subsidiary
7:42 AM MST | December 16, 2013 | Natasha Alperowicz
GlaxoSmithKline (GSK) today announced an offer to increase its stake in its publicly listed pharmaceutical subsidiary in India, GlaxoSmithKline Pharmaceuticals Ltd., from 50.7% to 75% at a price of 3,100 Indian rupee/share ($50.21). GSK intends to keep the company listed. Securities regulations in India require a minimum public shareholding of 25% for a company to maintain a public listing. The offer is for the acquisition of up to 20,609,775 shares, representing 24.3% of the total outstanding shares of the Indian company. The offer represents a premium of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee